Inhibitory effect of Magnolia Officinalis and lovastatin on aortic oxidative stress and apoptosis in hyperlipidemic rabbits

Journal of Cardiovascular Pharmacology

Volumn 47, Issue 3, 2006, Pages 463-468

  Chang, Weng Cheng ^a   Yu, Ya Mei ^a   Hsu, Yuan Man ^a   Wu, Chieh Hsi ^a   Yin, Pao Lun ^a   Chiang, Su Yin ^a   Hung, Jui Sung ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Hyperlipidemia; Lovastatin; Magnolia officinalis; Oxidative stress; Rabbit

Indexed keywords

CASPASE 8; CASPASE 9; FAS LIGAND; FREE RADICAL; HERBACEOUS AGENT; MAGNOLIA OFFICINALIS EXTRACT; MALONALDEHYDE; MEVINOLIN; UNCLASSIFIED DRUG; 8 HYDROXYDEOXYGUANOSINE; 8-HYDROXY-2'-DEOXYGUANOSINE; CASPASE; CHOLESTEROL; DEOXYGUANOSINE; DRUG DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEMBRANE PROTEIN; PLANT EXTRACT; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ARCH; APOPTOSIS; ARTERY LESION; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL DIET; COMPARATIVE STUDY; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; GENE EXPRESSION; HERBAL MEDICINE; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPID DIET; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; ANIMAL; BLOOD; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; MAGNOLIACEAE; METABOLISM; PATHOLOGY; THORACIC AORTA;

ANIMALS; AORTA, THORACIC; APOPTOSIS; CASPASE 8; CASPASE 9; CASPASES; CHOLESTEROL; DEOXYGUANOSINE; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; LOVASTATIN; MAGNOLIA; MALONDIALDEHYDE; MEMBRANE GLYCOPROTEINS; OXIDATIVE STRESS; PLANT EXTRACTS; RABBITS; TUMOR NECROSIS FACTORS;

EID: 33745713612     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000211708.03111.6e     Document Type: Article

References (44)

1. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-241.
2. Massy ZA, Keane WF. Pathogenesis of atherosclerosis. Semin Nephrol. 1996;16:12-20.
3. Yamashita S, Maruyama T, Hirano K, et al. Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia. Atherosclerosis. 2000;152:271-285.
4. Yla-Herttuala S, Luoma J, Kallionpaa H, et al. Pathogenesis of atherosclerosis. Maturitas. 1996;23(Suppl.):S47-S49.
5. Fruchart JC, Duriez P. High-density lipoproteins and coronary heart disease. Future prospects in gene therapy. Biochimie. 1998;80:167-172.
6. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med. 1996;20:707-727.
7. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
8. Fang YZ, Yang S, Wu G. Free radicals, antioxidants, and nutrition. Nutrition. 2002;18:872-879.
9. Hegele RA. The pathogenesis of atherosclerosis. Clin Chim Acta. 1996;246:21-38.
10. Holvoet P, Perez G, Zhao Z, et al. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease. J Clin Invest. 1995;95:2611-2619.
11. Wu LL, Chiou CC, Chang PY, et al. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta. 2004;339:1-9.
12. Martinet W, Knaapen MW, De Meyer GR, et al. Oxidative DNA damage and repair in experimental atherosclerosis are reversed by dietary lipid lowering. Circ Res. 2001;88:733-739.
13. Martinet W, Knaapen MW, De Meyer GR, et al. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation. 2002;106:927-932.
14. Lodovici M, Casalini C, Cariaggi R, et al. Levels of 8- hydroxydeoxyguanosine as a marker of DNA damage in human leukocytes. Free Radic Biol Med. 2000;28:13-17.
15. Kockx MM, Herman AG. Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc Res. 2000;45:736-746.
16. de Nigris F, Lerman A, Ignarro LJ, et al. Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis. Trends Mol Med. 2003;9:351-359.
17. Schneider DB, Vassalli G, Wen S, et al. Expression of Fas ligand in arteries of hypercholesterolemic rabbits accelerates atherosclerotic lesion formation. Arterioscler Thromb Vasc Biol. 2000;20:298-308.
18. Geng YJ. Molecular signal transduction in vascular cell apoptosis. Cell Res. 2001;11:253-264.
19. Wernig F, Xu Q. Mechanical stress-induced apoptosis in the cardiovascular system. Prog Biophys Mol Biol. 2002;78:105-137.
20. Bennett MR. Apoptosis in the cardiovascular system. Heart. 2002;87:480-487.
21. Kannan K, Jain SK. Oxidative stress and apoptosis. Pathophysiology. 2000;7:153-163.
22. Qureshi AA, Peterson DM. The combined effects of novel tocotrienols and lovastatin on lipid metabolism in chickens. Atherosclerosis. 2001;156:39-47.
23. Otto J, Ordovas JM, Smith D, et al. Lovastatin inhibits diet induced atherosclerosis in F1B Golden Syrian hamsters. Atherosclerosis. 1995;114:19-28.
24. Blankenhorn DH, Azen SP, Kramsch DM, et al. Coronary angiographic changes with lovastatin therapy: The Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med. 1993;119:969-976.
25. Tseng CM, Yu SM, Chen CC, et al. EDRF-release and Ca-channel blockade by magnolol. An antiplatelet agent isolated from Chinese herb Magnolia officinalis, in rat thoracic aorta. Life Sci. 1990;47:1153-1161.
26. Chang WS, Chang YH, Lu FJ, et al. Inhibitory effects of phenolics on xanthine oxidase. Anticancer Res. 1994;14:501-506.
27. Li CY, Wang Y, Hu MK. Allylmagnolol, a novel magnolol derivative as potent antioxidant. Bioorg Med Chem. 2003;11:3665-3671.
28. Chiu JH, Ho CT, Wei YH, et al. In vitro and in vivo protective effect of Honokiol on rat liver from lipid peroxidative injury. Life Sci. 1997;61:1967-1971.
29. Liou KT, Shen YC, Chen CF, et al. The anti-inflammatory effect of honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production. Br J Pharmacol. 2003;475:19-27.
30. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351-358.
31. Imaeda A, Kaneko T, Aoki T, et al. DNA damage and the effect of antioxidants in streptozotocin-treated mice. Food Chem Toxicol. 2002;40:979-987.
32. Sun JS, Hang YS, Huang IH, et al. A simple chemiluminescence assay for detecting oxidative stress in ischemic limb injury. Free Radic Biol Med. 1996;20:107-112.
33. Hsieh CL, Tang NY, Chiang SY, et al. Anticonvulsive and free radical scavenging actions of two herbs, Uncaria rhynchophylla (MIQ) Jack and Gastrodia elata Bl., in kainic acid-treated rats. Life Sci. 1999;65:2071-2082.
34. Lee YM, Hsiao G, Chen HR, et al. Magnolol reduces myocardial ischemia/reperfusion injury via neutrophil inhibition in rats. Eur J Pharmacol. 2001;422:159-167.
35. Chen YL, Lin KF, Shiao MS, et al. Magnolol, a potent antioxidant from Magnolia officinalis, attenuates intimal thickening and MCP-1 expression after balloon injury of the aorta in cholesterol-fed rabbits. Basic Res Cardiol. 2001;96:353-363.
36. Pitman WA, Osgood DP, Smith D, et al. The effects of diet and lovastatin on regression of fatty streak lesions and on hepatic and intestinal mRNA levels for the LDL receptor and HMG CoA reductase in F1B hamsters. Atherosclerosis. 1998;138:43-52.
37. Yu YM, Chang WC, Wu CH, et al. Reduction of oxidative stress and apoptosis in hyperlipidemic rabbits by ellagic acid. J Nutr Biochem. 2005;16:675-681.
38. Chan PT, Fong WP, Cheung YL, et al. Jasmine green tea epicathechins are hypolipidemic in hamsters (Meoscricetus auratus) fed a high fat diet. J Nutr. 1999;129:1094-1101.
39. Tikkanen MJ, Wahalnk OS, Vihma V, et al. Effect of soybean phytoestrogen intake on low-density lipoprotein oxidation resistance. Proc Natl Acad Sci U S A. 1998;95:3106-3110.
40. Li CY, Wang Y, Hu MK. Allylmagnolol, a novel magnolol derivative as potent antioxidant. Bioorganic Med Chem. 2003;11:3665-3671.
41. Gardner CD, Coulston A, Chatterjee L, et al. The effect of a plant-bases diet on plasma lipids in hypercholesterolemic adults. A randomized trial. Ann Internal Med. 2005;142:725-733.
42. Chiu JH, Wang JC, Lui WY, et al. Effect of magnolol on in vitro mitochondrial lipid peroxidation and isolated cold-preserved warm-reperfused rat livers. J Surg Res. 1999;82:11-16.
43. Chiu JH, Ho CT, Wei YH, et al. In vitro and in vivo protective effect of honokiol on rat liver from peroxidative injury. Life Sci. 1997;61:1961-1971.
44. Lo YC, Teng CM, Chen CF, et al. Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation. Biochem Pharmacol. 1994;47:549-553.